These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7567319

  • 21. An economic analysis of rotavirus vaccination in Italy.
    Giammanco MD, Coniglio MA, Pignato S, Giammanco G.
    Vaccine; 2009 Jun 12; 27(29):3904-11. PubMed ID: 19446934
    [Abstract] [Full Text] [Related]

  • 22. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA, Winston FK, Kallan MJ, Branas CC, Schwartz JS.
    Ambul Pediatr; 2008 Jun 12; 8(1):58-65. PubMed ID: 18191783
    [Abstract] [Full Text] [Related]

  • 23. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.
    Clin Ther; 2008 Feb 12; 30(2):341-57. PubMed ID: 18343273
    [Abstract] [Full Text] [Related]

  • 24. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE, Active Bacterial Core Surveillance Team.
    Clin Infect Dis; 2008 Jan 01; 46(1):1-13. PubMed ID: 18171206
    [Abstract] [Full Text] [Related]

  • 25. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
    Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S76-84. PubMed ID: 19817618
    [Abstract] [Full Text] [Related]

  • 26. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP.
    Pediatrics; 2007 Jan 01; 119(1):e22-9. PubMed ID: 17200247
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.
    Vaccine; 2012 Feb 14; 30(8):1521-8. PubMed ID: 22119590
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan.
    Sato T, Nakagomi T, Nakagomi O.
    Jpn J Infect Dis; 2011 Feb 14; 64(4):277-83. PubMed ID: 21788701
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J, Sartori AM, de Soárez PC, Amaku M, Azevedo RS, Novaes HM.
    Vaccine; 2008 Nov 18; 26(49):6281-91. PubMed ID: 18674582
    [Abstract] [Full Text] [Related]

  • 37. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E, Galvani AP.
    Vaccine; 2009 Jun 19; 27(30):4025-30. PubMed ID: 19389452
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.
    Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR.
    Pediatrics; 1995 May 19; 95(5):632-8. PubMed ID: 7724297
    [Abstract] [Full Text] [Related]

  • 40. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.
    Vaccine; 2004 Mar 12; 22(9-10):1138-49. PubMed ID: 15003641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.